Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors.
Garcia de Herreros M, Jiménez N, Rodríguez-Carunchio L, Lillo E, Marín-Aguilera M, Ferrer-Mileo L, Aversa C, García-Esteve S, Padrosa J, Trias I, Fernández-Mañas L, Font A, Chirivella I, Figols M, Climent MÁ, Prat A, Reig Ò, Mellado B.
Garcia de Herreros M, et al. Among authors: lillo e.
Eur Urol Open Sci. 2024 Oct 21;70:86-90. doi: 10.1016/j.euros.2024.10.008. eCollection 2024 Dec.
Eur Urol Open Sci. 2024.
PMID: 39502104
Free PMC article.